Centessa Pharmaceuticals
Neurology & CNS Therapeutics · Prescription Drugs
4open roles
4backers · Wellington Management, CIC
Growinghiring pace, 64 of 100
61team · US Form 5500 (plan participants) · Dec 2024
Overview
Centessa Pharmaceuticals is a transformational pharmaceutical brand that aims to discover and develop medicines that can have a profound impact on patients' lives. With an asset-centric and patient-centric approach, Centessa is committed to redefining the way medicines are made. Led by a team of leaders, innovators, and entrepreneurs, Centessa is dedicated to revolutionizing the pharmaceutical industry by bringing together the best minds in science and business. Centessa's pipeline encompasses a range of ongoing clinical trials that focus on developing groundbreaking treatments. They prioritize the expansion of patient access to these innovative therapies through their expanded access policy. Investors are also an integral part of Centessa's vision, providing support and resources to further propel their research and development efforts. With a strong emphasis on privacy and regulatory compliance, Centessa ensures that patients' confidentiality is protected and their personal information is handled with utmost care. If you want to stay updated on the latest news and career opportunities at Centessa, you can follow them on their website and social media platforms. Centessa Pharmaceu
Funding and backers
Team
61
US Form 5500 (plan participants) · Dec 2024
Hiring now
10
open roles
Backers
4
Wellington Management, CIC
Momentum
0/100
no fresh signals
Last sign of life
1 mo ago
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
2021
Founded
Tractionpublic signals, read monthly
Web presence
top 8%
of 133.2M domains by links, Common Crawl
Backed byfrom the funds' portfolios and accelerator catalogs
Wellington Management 
EcoR1 Capital 
Foresite Capital Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
NeuroDerm is an agile and entrepreneurial R&D company, driving healthcare innovation and patient-centric solutions through Pharma & MedTech…
Luxna Biotech is a preclinical-stage Japanese biotechnology company that develops antisense oligonucleotide (ASO) therapeutics using novel…
Engrail delivers transformational therapies that improve the lives of patients with devastating neurologic, neuropsychiatric, and…
Our Mission. Deliver medicines that transform the lives of patients with neurodegenerative diseases.
Lisata is a clinical-stage pharmaceutical company dedicated to improving lives through the discovery, development, and commercialization of…
A biotech company dedicated to developing transformative medicines for people with neurodegenerative diseases using cutting-edge science…
Jobs
In office · Full-Time · 12+ years exp · Bachelor's Degree · London
Apply
$130k – $180k per year · Remote (United States) · Contractor · 5+ years exp · Bachelor's Degree · Boston
GCP
Apply
$130k – $170k per year · In office · Contractor · 4+ years exp · PhD · Boston
GCP
Management
SharePoint
Life Sciences
Good Clinical Practice
Apply
≈ $132k – $233k per year (Estimated) · In office · Contractor · 8+ years exp · Bachelor's Degree · Boston
GCP
Apply
Salary insights
Compensation ranges based on this company's open jobs
Median
$170k
Typical range
$160k – $180k
Open positions
3
3
Jobs
Middle
33.3%
Senior
66.7%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Middle | 1 | $160k | $160k |
| Senior | 2 | $175k | $170k – $180k |
Highest paying role
Clinical Trial Manager (Contract)
$180k
Normalized to USD per year
Visa sponsorship
1
H-1B filings in 12 months
$218k
Median offered salary
4
Open roles in United States
Who they sponsor
Statisticians
1
In the register as CENTESSA PHARMACEUTICALS, LLC, Boston, MA
Other sponsors in the same field
AbbVie 
Biogen 
Novartis
See 4 open roles Alert me
US Department of Labor · latest filing Aug 7, 2025 · Visa details by country
Growth
Hiring Momentum
64/100
Growing
Open positions
5
0 opened / 16 closed in 30 days
Median time-to-fill
53 days
faster than 25% of the market
ATS activity
Every ~5 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Early Careers
38% ▼
Biotech
38% ▲
Management
7% ▲
Operations
7% ▼
Industrial Engineering
7% ▼
Administrative
3% ▼
Activity Timeline
Added Design History File to stack
Oct 2026
Added Design Controls to stack
Oct 2026
Added Veeva to stack
Oct 2026
Added Good Clinical Practice to stack
Oct 2026
Added ICH Guidelines to stack
Oct 2026
Added GMP to stack
Oct 2026
Added CAPA to stack
Oct 2026
Added GraphPad Prism to stack
Oct 2026
Added GLP to stack
Oct 2026
New location: Atlanta
Sep 2026
Added Amazon ECS to stack
Sep 2026
Added Python to stack
Sep 2026
Tech stack
Technologies named in job postings at Centessa Pharmaceuticals over the last 12 months, by layer, with the share of postings for each.
Technologies in use
13
Postings analysed
15
Stack modernity
54/100
Languages
Python7%
Cloud & platforms
GCP40%
Amazon ECS7%
Sign in to see how your skills match this stack
Sign In
Full Centessa Pharmaceuticals tech stack
13 technologies · by team · pay by technology · changes · similar stacks
Connections
List
Graph
Found in company registers, site code, DNS and hiring. Each connection shows how sure we are and the evidence, with its source and date.
Shared investors
Show all 4 
Click a company to open it. Dashed lines are likely connections. The second step of the network is part of the Pro plan.
Owner
Same company
Same group
Likely
News
Centessa Pharmaceuticals to Participate in Upcoming Investor Conferences - Company Announcement - FT.com
The latest company information, including net asset values, performance, holding & sectors weighting, changes in voting rights, and directors and dealings.
Read more
Report
Analysts Are Bullish on These Healthcare Stocks: Palisade Bio (PALI), Centessa Pharmaceuticals (CNTA)
Detailed price information for Palisade Bio Inc (PALI-Q) from The Globe and Mail including charting and trades.
Read more
Report
Why Centessa Pharmaceuticals Stock Crushed the Market Today
Investors were optimistic about the company potentially reaping $250 million in gross proceeds from an equity offering.
Read more
Report
Centessa Pharmaceuticals Secures $200 Million Loan Deal
Don't Miss Our New Year's Offers:Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top StocksMake smarter investments with weekly expert stock picks from the Smart Investor NewsletterCentessa Pharmaceuticals
Read more
Report
Sleep-Disorder Focused Centessa Pharmaceuticals Unveils Interim Data From Lead Program In Acutely Sleep-Deprived Healthy Volunteers
Read more
Report
Centessa Pharmaceuticals: Clinical Advances And Unique Business Model Highlight Growth Potential
Read more
Report
Enrollment progressing toward interim analysis planned when 36 subjects reach 12 weeks on treatment in Part 1 of study
Read more
Report
Centessa Pharmaceuticals plc (NASDAQ:CNTA) most popular amongst private equity firms who own 42% of the shares, institutions hold 28%
Every investor in Centessa Pharmaceuticals plc (NASDAQ:CNTA) should be aware of the most powerful shareholder groups. And the group that holds the biggest piece of the pie are private equity firms with 42% ownership. That is, the group stands to benefit t
Read more
Report
Show more news
Offices
Where the company hires and what each office is for
Cities
2
Hiring now
2
Countries
2
Busiest office
Boston
Loading the map
Headquarters
Builds here
Office with open vacancies
Tap a pin for the office
Boston
United States
HQ
4 open roles 29 posted in 90 days 50% remote 200-500 est. staff $170k Avg Salary
hires for Biotech, Administrative
London
United Kingdom
1 open roles 1 posted in 90 days 10-50 est. staff
hires for Biotech